Ratings by TD Cowen (Doug Schenkel)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/25/2022 | Invitae Corporation | NVTA | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2021 | Invitae Corporation | NVTA | Maintain | Buy (N/A) |
|
Details | ||
| 9/23/2021 | Thermo Fisher Scientific | TMO | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2021 | Sophia Genetics SA | SOPH | New Coverage | Buy (N/A) |
18.09 (4.95) |
-72.64% | Details | |
| 8/16/2021 | Absci Corp. | ABSI | New Coverage | Hold (N/A) |
25.01 (4.46) |
-82.17% | Details | |
| 8/9/2021 | Sera Prognostics Inc | SERA | New Coverage | Buy (N/A) |
12.89 (10.34) |
-19.78% | Details | |
| 8/4/2021 | Zymergen Inc | ZY | Downgrade | Hold (Buy) |
34.83 (2.43) |
-93.02% | Details | |
| 8/3/2021 | Waters Corp. | WAT | Maintain | Hold (N/A) |
|
Details | ||
| 7/29/2021 | Thermo Fisher Scientific | TMO | Maintain | Buy (N/A) |
|
Details | ||
| 7/22/2021 | Danaher | DHR | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2021 | Codex DNA Inc. | DNAY | New Coverage | Buy (N/A) |
16.57 (1.30) |
-92.15% | Details | |
| 7/1/2021 | Waters Corp. | WAT | Maintain | Hold (N/A) |
|
Details | ||
| 7/1/2021 | 10X Genomics | TXG | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2021 | Qiagen NV | QGEN | Maintain | Hold (N/A) |
|
Details | ||
| 7/1/2021 | Pacific Biosciences of California | PACB | Maintain | Hold (N/A) |
|
Details | ||
| 7/1/2021 | Natera | NTRA | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2021 | Guardant Health | GH | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2021 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2021 | Codexis, Inc. | CDXS | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2021 | Avantor Inc. | AVTR | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2021 | Amyris, Inc. | AMRS | Maintain | Buy (N/A) |
|
Details | ||
| 6/21/2021 | Singular Genomics | OMIC | New Coverage | Buy (N/A) |
23.90 (0.40) |
-98.33% | Details | |
| 5/17/2021 | Zymergen Inc | ZY | New Coverage | Buy (N/A) |
31.92 (2.43) |
-92.39% | Details | |
| 3/17/2021 | GenMark Diagnostics | GNMK | Downgrade | Hold (Buy) |
23.98 (24.04) |
0.25% | Details | |
| 2/24/2021 | Myriad Genetics | MYGN | Maintain | Hold (N/A) |
|
Details | ||
| 2/4/2021 | Avantor Inc. | AVTR | Maintain | Buy (N/A) |
|
Details | ||
| 2/2/2021 | Waters Corp. | WAT | Maintain | Buy (N/A) |
|
Details | ||
| 2/1/2021 | Thermo Fisher Scientific | TMO | Maintain | Buy (N/A) |
|
Details | ||
| 1/12/2021 | 908 Devices Inc. | MASS | New Coverage | Buy (N/A) |
56.63 (5.56) |
-90.18% | Details | |
| 1/6/2021 | Amyris, Inc. | AMRS | Upgrade | Buy (Hold) |
9991.28 (9456.90) |
-5.35% | Details | |
| 1/6/2021 | NanoString Tech | NSTG | Upgrade | Buy (Hold) |
68.42 (0.11) |
-99.84% | Details | |
| 12/29/2020 | Seer Inc. | SEER | New Coverage | Buy (N/A) |
64.40 (1.75) |
-97.28% | Details | |
| 11/25/2020 | Amyris, Inc. | AMRS | New Coverage | Hold (N/A) |
2.62 (9456.90) |
360850.38% | Details | |
| 11/10/2020 | Myriad Genetics | MYGN | Maintain | Hold (N/A) |
|
Details | ||
| 11/6/2020 | Codexis, Inc. | CDXS | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2020 | Invitae Corporation | NVTA | Maintain | Buy (N/A) |
|
Details | ||
| 10/27/2020 | Waters Corp. | WAT | Maintain | Hold (N/A) |
|
Details | ||
| 10/7/2020 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 9/28/2020 | DexCom | DXCM | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2020 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2020 | 10X Genomics | TXG | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2020 | Codexis, Inc. | CDXS | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2020 | Natera | NTRA | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2020 | Bruker | BRKR | Maintain | Hold (N/A) |
|
Details | ||
| 7/31/2020 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 7/28/2020 | Waters Corp. | WAT | Maintain | Hold (N/A) |
|
Details | ||
| 7/24/2020 | DexCom | DXCM | Maintain | Buy (N/A) |
|
Details | ||
| 7/22/2020 | Thermo Fisher Scientific | TMO | Maintain | Buy (N/A) |
|
Details | ||
| 7/8/2020 | Twist Bioscience | TWST | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2020 | Burning Rock Biotech Ltd. | BNR | New Coverage | Buy (N/A) |
26.46 (0.85) |
-96.79% | Details | |
| 7/6/2020 | Thermo Fisher Scientific | TMO | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2020 | Avantor Inc. | AVTR | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2020 | Hologic | HOLX | Upgrade | Buy (Hold) |
53.33 (75.71) |
41.97% | Details | |
| 6/26/2020 | Invitae Corporation | NVTA | Maintain | Buy (N/A) |
|
Details | ||
| 6/19/2020 | GenMark Diagnostics | GNMK | Maintain | Buy (N/A) |
|
Details | ||
| 6/9/2020 | DexCom | DXCM | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2020 | Codexis, Inc. | CDXS | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2020 | GenMark Diagnostics | GNMK | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2020 | GenMark Diagnostics | GNMK | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2020 | Exagen | XGN | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2020 | Danaher | DHR | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2020 | Tandem Diabetes Care | TNDM | Maintain | Buy (N/A) |
|
Details | ||
| 2/20/2020 | Invitae Corporation | NVTA | Maintain | Buy (N/A) |
|
Details | ||
| 2/20/2020 | Invitae Corporation | NVTA | Maintain | Buy (N/A) |
|
Details | ||
| 2/19/2020 | 10X Genomics | TXG | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2020 | DexCom | DXCM | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2020 | Tandem Diabetes Care | TNDM | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2020 | Tandem Diabetes Care | TNDM | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2020 | Qiagen NV | QGEN | Maintain | Hold (N/A) |
|
Details | ||
| 2/5/2020 | Waters Corp. | WAT | Maintain | Hold (N/A) |
|
Details | ||
| 1/7/2020 | DexCom | DXCM | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2020 | Exagen | XGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2020 | Waters Corp. | WAT | Maintain | Hold (N/A) |
|
Details | ||
| 1/6/2020 | 10X Genomics | TXG | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2020 | Thermo Fisher Scientific | TMO | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2020 | Qiagen NV | QGEN | Maintain | Hold (N/A) |
|
Details | ||
| 1/6/2020 | PerkinElmer | PKI | Maintain | Hold (N/A) |
|
Details | ||
| 1/6/2020 | Pacific Biosciences of California | PACB | Maintain | Hold (N/A) |
|
Details | ||
| 1/6/2020 | Invitae Corporation | NVTA | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2020 | NanoString Tech | NSTG | Maintain | Hold (N/A) |
|
Details | ||
| 1/6/2020 | Hologic | HOLX | Maintain | Hold (N/A) |
|
Details | ||
| 1/6/2020 | Guardant Health | GH | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2020 | GenMark Diagnostics | GNMK | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2020 | Fluidigm Corporation | FLDM | Maintain | Hold (N/A) |
|
Details | ||
| 1/6/2020 | Danaher | DHR | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2020 | Bruker | BRKR | Maintain | Hold (N/A) |
|
Details | ||
| 1/6/2020 | Avantor Inc. | AVTR | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2019 | DexCom | DXCM | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2019 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2019 | Exagen | XGN | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2019 | 10X Genomics | TXG | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2019 | 10X Genomics | TXG | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2019 | DexCom | DXCM | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2019 | Myriad Genetics | MYGN | Maintain | Hold (N/A) |
|
Details | ||
| 11/4/2019 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 10/7/2019 | 10X Genomics | TXG | New Coverage | Buy (N/A) |
51.45 (26.90) |
-47.72% | Details | |
| 8/14/2019 | Pacific Biosciences of California | PACB | Maintain | Hold (N/A) |
|
Details | ||
| 8/7/2019 | Guardant Health | GH | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2019 | Fluidigm Corporation | FLDM | Maintain | Hold (N/A) |
|
Details | ||
| 7/29/2019 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 7/22/2019 | Adeptus Biotechnologies Corp. | ADPT | New Coverage | Buy (N/A) |
38.01 (2.61) |
-93.13% | Details | |
| 7/15/2019 | Personalis | PSNL | New Coverage | Buy (N/A) |
0.00 (1.25) |
0% | Details | |
| 7/9/2019 | Myriad Genetics | MYGN | Downgrade | Hold (Buy) |
27.65 (17.98) |
-34.97% | Details | |
| 6/28/2019 | Invitae Corporation | NVTA | Maintain | Buy (Buy) |
|
Details | ||
| 6/11/2019 | Avantor Inc. | AVTR | New Coverage | Buy (N/A) |
17.20 (25.15) |
46.22% | Details | |
| 5/7/2019 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 4/23/2019 | Waters Corp. | WAT | Maintain | Hold (N/A) |
|
Details | ||
| 4/4/2019 | Danaher | DHR | Maintain | Buy (Buy) |
|
Details | ||
| 3/8/2019 | NanoString Tech | NSTG | Maintain | Hold (N/A) |
|
Details | ||
| 2/27/2019 | Tandem Diabetes Care | TNDM | Maintain | Buy (N/A) |
|
Details | ||
| 2/22/2019 | DexCom | DXCM | Maintain | Buy (Buy) |
|
Details | ||
| 2/12/2019 | NanoString Tech | NSTG | Maintain | Hold (N/A) |
|
Details | ||
| 2/12/2019 | Bruker | BRKR | Maintain | Hold (N/A) |
|
Details | ||
| 1/31/2019 | Hologic | HOLX | Maintain | Hold (N/A) |
|
Details | ||
| 1/4/2019 | Myriad Genetics | MYGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2019 | Pacific Biosciences of California | PACB | Downgrade | Hold (Buy) |
7.40 (1.38) |
-81.35% | Details | |
| 1/4/2019 | Hologic | HOLX | Downgrade | Hold (Buy) |
38.42 (53.33) |
38.81% | Details | |
| 1/4/2019 | Myriad Genetics | MYGN | Upgrade | Buy (Hold) |
29.00 (27.65) |
-4.66% | Details | |
| 11/26/2018 | Twist Bioscience | TWST | New Coverage | Buy (N/A) |
25.45 (31.08) |
22.12% | Details | |
| 11/8/2018 | Hologic | HOLX | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2018 | Myriad Genetics | MYGN | Maintain | Hold (N/A) |
|
Details | ||
| 10/29/2018 | Guardant Health | GH | New Coverage | Buy (N/A) |
35.14 (17.16) |
-51.17% | Details | |
| 10/19/2018 | Pacific Biosciences of California | PACB | New Coverage | Buy (N/A) |
4.56 (7.40) |
62.28% | Details | |
| 9/5/2018 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/0019 | Hologic | HOLX | Downgrade | Hold (Buy) |
42.08 (75.71) |
79.92% | Details |
